Search research articles
Contact Us
Filters
Showing results (771-780 of 832) with videos related to
Page
of 84
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
October 27, 2022
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
Matthew W McCarthy, Susanna Naggie, David R Boulware, et al.
JAMA
|
January 12, 2023
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Matthew W McCarthy, Susanna Naggie, David R Boulware, et al.
Annals of Internal Medicine
|
July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial
Caleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Open Forum Infectious Diseases
|
August 25, 2023
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial
Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, et al.
Wellcome Open Research
|
October 22, 2020
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)
Suzaan Marais, Fiona V Cresswell, Raph L Hamers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 17, 2020
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 30, 2020
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
The Lancet. Global Health
|
April 27, 2025
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trials
Thomas H A Samuels, Sile F Molloy, David S Lawrence, et al.
The New England Journal of Medicine
|
June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
David R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
Page
of 84
Search research articles
Search
Showing results (771-780 of 832) with videos related to
Sort By:
Page
of 84
Medrxiv : the Preprint Server for Health Sciences
|
October 27, 2022
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
Matthew W McCarthy, Susanna Naggie, David R Boulware, et al.
JAMA
|
January 12, 2023
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Matthew W McCarthy, Susanna Naggie, David R Boulware, et al.
Annals of Internal Medicine
|
July 17, 2020
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial
Caleb P Skipper, Katelyn A Pastick, Nicole W Engen, et al.
Open Forum Infectious Diseases
|
August 25, 2023
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial
Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio, et al.
Wellcome Open Research
|
October 22, 2020
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)
Suzaan Marais, Fiona V Cresswell, Raph L Hamers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 17, 2020
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 30, 2020
Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, et al.
The Lancet. Global Health
|
April 27, 2025
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trials
Thomas H A Samuels, Sile F Molloy, David S Lawrence, et al.
The New England Journal of Medicine
|
June 4, 2020
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R Boulware, Matthew F Pullen, Ananta S Bangdiwala, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 22, 2023
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
David R Boulware, Mucunguzi Atukunda, Enock Kagimu, et al.
Page
of 84